Author | E. Shelley Hwang, MD, MPH

Articles

Current Trends in the Management of Ductal Carcinoma In Situ

September 15, 2016

This review will summarize the current trends in the diagnosis and management of DCIS and will highlight ongoing trials that are shaping future management of this entity.

The Current Clinical Value of the DCIS Score

May 15, 2014

ByWilliam C. Wood, MD

Michael Alvarado, MD

Daniel J. Buchholz, MD

David Hyams, MD

E. Shelley Hwang, MD, MPH

Jennifer Manders, MD

Catherine C. Park, MD

Lawrence J. Solin, MD

Julia White, MD

Shawna Willey, MD

The DCIS Score provides clinically relevant information about personal risk that can guide patient discussions and facilitate shared decision making.

The Impact of Lobular Histology on Breast Cancer Treatment

April 15, 2011

ByE. Shelley Hwang, MD, MPH

Breast cancers of lobular histology are not frequently encountered, but are nevertheless the second most common histologic subtype of breast cancer after ductal adenocarcinoma.

Commentary (Hwang/Esserman): Surgical Management of Hepatic Breast Cancer Metastases

November 01, 2005

ByE. Shelley Hwang, MD, MPH

Laura J. Esserman, MD, MBA

In this review of hepatic resectionfor metastatic breast cancer, theauthors argue that a small groupof women with isolated liver metastasesmay be appropriate candidates forsurgical resection. Although some datahave been reported, the few publishedstudies represent small, retrospectivesingle-institutional series with no standardizedcriteria for resection. Nevertheless,the potential prospect ofimproved patient outcome in the settingof liver metastases from breastcancer deserves further consideration.